These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 63724)

  • 1. Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
    Lagarde M; Dechavanne M
    Lancet; 1977 Jan; 1(8002):88. PubMed ID: 63724
    [No Abstract]   [Full Text] [Related]  

  • 2. Collagen stimulates more platelet prostaglandin endoperoxides in thrombosis.
    Lagarde M; Dechavanne M
    Biomedicine; 1977 Apr; 27(3):119-23. PubMed ID: 329906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet suppressive therapy.
    Turpie AG; Hirsh J
    Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application and evaluation of anti-platelet agents].
    Yasunaga K
    Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
    Avellone G; Mandalà V; Novo S; Pinto A; Riolo FP; Davì G; Raneli G
    Boll Soc Ital Cardiol; 1981; 26(8):697-712. PubMed ID: 6289854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical prevention of thrombosis by antiplatelet agents].
    Latour JG
    Union Med Can; 1979 Oct; 108(10):1168-86. PubMed ID: 392868
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
    McDonald JW; Stuart RK; Barnett HJ
    Adv Exp Med Biol; 1977; 82():222-4. PubMed ID: 920363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet function inhibitors in peripheral arteriopathies].
    Strano A; Davì G; Cannizzaro S; Giubilato A
    Recenti Prog Med; 1986 Apr; 77(4):205-9. PubMed ID: 2872704
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelets and prostaglandins in sudden death: therapeutic implications.
    Gelman JS; Mehta J
    Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
    Verdecchia P
    Clin Ter; 1982 Apr; 101(2):179-94. PubMed ID: 7047054
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulants.
    Forbes CD; Prentice CR
    Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy and prevention of acute phlebothrombosis with heparin, coumarins and inhibitors of platelet function].
    Schott G
    Z Arztl Fortbild (Jena); 1979 Jan; 73(1):23-7. PubMed ID: 419774
    [No Abstract]   [Full Text] [Related]  

  • 19. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of prostaglandin endoperoxides on platelet ultrastructure.
    Gerrard JM; White JG
    Am J Pathol; 1975 Aug; 80(2):189-202. PubMed ID: 169697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.